Article
Quality of Life Scores Remained Different among the Genotypic Groups of Patients with Suspected Hemochromatosis, Even after Treatment Period.
Genes - 10 Jan 2022
Acevedo Luis Alfredo Utria, Alvarenga Aline Morgan, Fonseca Paula Fernanda Silva, da Silva Nathália Kozikas, Cançado Rodolfo Delfini, Naoum Flavio Augusto, Dinardo Carla Luana, Pereira Alexandre Costa, Brissot Pierre, Santos Paulo Caleb Junior Lima
Abstract excerpt
BACKGROUND: Hemochromatosis is a genetic condition of iron overload caused by deficiency of hepcidin. In a previous stage of this study, patients with suspected hemochromatosis had their quality of life (QL) measured. We observed that QL scores differed among genotypic groups of patients. In this reported final phase of the study, the aims were to compare QL scores after a treatment period of approximately 3...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.